EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ebola vaccine trial halted early – safety data collected
⭐️ VACCINE ⭐️ TerminatedThis study tested two experimental Ebola vaccines in 38 healthy adults in the UK. One group received a single vaccine, while others got a booster after two or four weeks. The goal was to check safety and measure immune responses. The trial was terminated early, but the data helps…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:34 UTC
-
Ebola vaccine nasal spray tested in humans – study halted early
⭐️ VACCINE ⭐️ TerminatedThis early-stage study tested a new Ebola vaccine given as a nasal spray in 15 healthy adults. The goal was to check safety and whether the vaccine triggers an immune response. The study was terminated early, so results are limited.
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:56 UTC